Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Description of key information

A modern, guideline-compliant mouse LLNA is avai;abe for amyl cinnamic aldehyde

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1 December 2005 to 7 April 2006
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline compliant and GLP study with no deficiencies
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes
Type of study:
mouse local lymph node assay (LLNA)
Species:
mouse
Strain:
other: CBA/Ca/Ola/Hsd
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Interfauna UK Ltd
- Age at study initiation: 8-12 weeks
- Weight at study initiation:
- Housing: groups of four per cage
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C):22+/-3°C
- Humidity (%):30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 7 December 2005 To: 13 December 2005
Vehicle:
other: 1:3 ethanol:diethylphthalate and 4:1 acetone:olive oil for the positive control
Concentration:
1, 2.5, 5, 10 or 25% w/v
No. of animals per dose:
Four females
Details on study design:

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response: One or more concentration should elicit a 3-fold or greater increase in isotope incorporation.

TREATMENT PREPARATION AND ADMINISTRATION: The mice were acclimatised for a period of 5 days prior to dosing. Groups of four females were allocated to each group. Alpha amyl-cinnamaldehyde was formulated in 1:3 EtOH:DEP and administered by painting the dorsal surface of each ear with25 µl of 1, 2.5, 5, 10 or 25 % w/v on three consecutive days. Three days after the last application all animals were injected via the tail vein with 250 µl of phosphate buffered saline containing 20µCi of a 2.0 Ci/mmol specific activity tritiated methylthymidine. After five hours the mice were terminated and draining auricular lymph nodes were removed from each mouse. The nodes were pooled per group. A single cell suspension was prepared from the disaggregated lymph nodes. After preparation the lymph node suspensions were transferred to scintillation vials and Optiphase scintillant was added prior to counting with a liquid scintillation counter.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
The EC3 value was calculated from the standard formula EC3 = [(3-d)/(b-d)] x (a-c) +c by interpolating between two points on the Stimulation Index axis.
The quantity applied per square centimetre was derived from the EC3 value assuming the area of the mouse ear equates to 1 cm2 and that 1µl is equivalent to 1 mg.
Positive control results:
A positive response was shown to HCA at concentrations of 10% (SI = 4.2) and 25% w/v (SI = 15.1), confirming the sensitivity of the assay.
Parameter:
SI
Value:
1.6
Test group / Remarks:
2.5% amyl cinnamic aldehyde
Parameter:
SI
Value:
1.7
Test group / Remarks:
1% amyl cinnamic aldehyde
Parameter:
SI
Value:
1.8
Test group / Remarks:
5% amyl cinnamic aldehyde
Parameter:
SI
Value:
4.1
Test group / Remarks:
10% amyl cinnamic aldehyde
Parameter:
SI
Value:
10.2
Test group / Remarks:
25% amyl cinnamic aldehyde
Parameter:
EC3
Value:
7.6
Remarks on result:
other:
Remarks:
7.6% w/v is equivalent to 1900 µg/cm2
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: 3029, 5191, 4932, 5338, 12431 and 30873 dpm for the vehicle control and groups dosed at 1, 2.5, 5, 10 and 25 % w/v respectively.

SI Values

Substance

Concentration (w/v)

SI

Amyl cinnamic aldehyde

0 (vehicle)

-

1%

1.7

2.5%

1.6

5%

1.8

10%

4.1

25%

10.2

Hexyl cinnamic aldehyde

0

-

5%

2.3

10%

4.2

25%

15.1

Interpretation of results:
sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Alpha-amyl cinnamaldehyde was a skin sensitiser under the conditions of the LLNA, with an EC3 value of 7.6% w/v or 1900 µg/cm2.
Executive summary:

Alpha-amyl cinnamaldehyde was assessed for sensitising potential in the murine LLNA . Dose levels of 1, 2.5, 5, 10 and 25% w/v were applied in 1:3 ethanol:diethylphthalate. The two higher doses, 10 and 25% w/v caused an increase in lymphocyte proliferation that was greater than 3 -fold compared with the vehicle control. The EC3 value was 7.6% w/v or 1900 µg/cm2.

Alpha-amyl cinnamaldehyde was found to be a potential sensitiser under the conditions of this study and would require classification

in sub-Category 1B according to the 2nd ATP of the CLP Regulation

1272/2008

. .

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

A modern, guideline-compliant mouse LLNA reports a positive response to amyl cinnamic aldehyde at concentrations of 10 and 25% w/v; an EC3 value of 7.6% is calculated.

The skin sensitisation potential identified in mice is not substantiated in human volunteer RIPT investigations where only slight transient and non-specific responses were observed and the conclusion for each of 7 assays in humans was that no evidence for skin sensitisation was found in humans. However the similarity of ACA to HCA which is used as a positive control for dermal sensitisation assays, indicates the LLNA result should be considered valid, rather than a false positive, and predictive of sensitising potential for cinnamic aldehydes, even if this is only expressed in sensitive human individuals.

Migrated from Short description of key information:

Determination of sensitising potential as indicated by lymphocyte proliferation in a murine local lymph node assay.

Additional supporting information is presented in reports of human exposure.

Justification for selection of skin sensitisation endpoint:

Positive result reported

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

The results of the mouse LLNA trigger classification of amyl cinnamic aldehyde as a skin sensitiser: the EC3 value of 7.6% from this study indicates classification in sub-Category 1B according to the 2nd ATP of the CLP Regulation.